Takeda Pharmaceutical Company Limited (TAK) stock analysis

In our weekly check, Takeda Pharmaceutical Company Limited is graded C (A to F). Of 21 checks on debt, profit, cash flow and trend: 9 pass, warnings: 6, red flags: 6.

Sector: Healthcare · Drug Manufacturers - Specialty & Generic

Strengths

Warning signs

Next earnings report: 2026-10-29

Similar companies

TEVA · ZTS · VTRS · ELAN · LNTH · AMRX

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks graded D or F lost a third of their value 2-3 times as often as those graded A or B.

Updated 2026-10-03

Open the full analysis